[go: up one dir, main page]

AR010517A1 - COMPOUNDS AND METHODS FOR TUBERCULOSIS IMMUNOTHERAPY AND DIAGNOSIS - Google Patents

COMPOUNDS AND METHODS FOR TUBERCULOSIS IMMUNOTHERAPY AND DIAGNOSIS

Info

Publication number
AR010517A1
AR010517A1 ARP970104711A AR010517A1 AR 010517 A1 AR010517 A1 AR 010517A1 AR P970104711 A ARP970104711 A AR P970104711A AR 010517 A1 AR010517 A1 AR 010517A1
Authority
AR
Argentina
Prior art keywords
tuberculosis
compounds
diagnosis
methods
immunotherapy
Prior art date
Application number
Other languages
Spanish (es)
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/818,112 external-priority patent/US6290969B1/en
Application filed by Corixa Corp filed Critical Corixa Corp
Publication of AR010517A1 publication Critical patent/AR010517A1/en

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Compuestos y métodos para inducir inmunidad protectora contra tuberculosis. Los compuestos provistos incluyen polipéptidos que contienenpor lo menos una porcion inmunogénica de una o más proteínas de M.tuberculosis y moléculas de ADN que codifican dichos polipéptidos. Dichos compuestos puedenformularse en vacunas y/o en composiciones farmacéuticas para inmunizacion contra la infeccion causada por M. tuberculosis, o pueden usarse para eldiagnostico de la tuberculosis.Compounds and methods for inducing protective immunity against tuberculosis. The provided compounds include polypeptides containing at least an immunogenic portion of one or more M. tuberculosis proteins and DNA molecules encoding such polypeptides. Said compounds can be formulated in vaccines and / or in pharmaceutical compositions for immunization against infection caused by M. tuberculosis, or they can be used for the diagnosis of tuberculosis.

ARP970104711 1996-10-11 1997-10-13 COMPOUNDS AND METHODS FOR TUBERCULOSIS IMMUNOTHERAPY AND DIAGNOSIS AR010517A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73051096A 1996-10-11 1996-10-11
US08/818,112 US6290969B1 (en) 1995-09-01 1997-03-13 Compounds and methods for immunotherapy and diagnosis of tuberculosis

Publications (1)

Publication Number Publication Date
AR010517A1 true AR010517A1 (en) 2000-06-28

Family

ID=40930091

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP970104711 AR010517A1 (en) 1996-10-11 1997-10-13 COMPOUNDS AND METHODS FOR TUBERCULOSIS IMMUNOTHERAPY AND DIAGNOSIS

Country Status (2)

Country Link
AR (1) AR010517A1 (en)
CO (1) CO4700484A1 (en)

Also Published As

Publication number Publication date
CO4700484A1 (en) 1998-12-29

Similar Documents

Publication Publication Date Title
PT851927E (en) COMPOUNDS FOR IMMUNOTHERAPY AND TUBERCULOSIS DIAGNOSIS
NO20075900L (en) Compounds for immunotherapy and diagnosis of tuberculosis and methods for their use
NO991694L (en) Compounds and methods for immunotherapy and diagnosis of tuberculosis
WO1999042076A3 (en) Compounds and methods for immunotherapy and diagnosis of tuberculosis
WO2002024739A3 (en) Spas-1 cancer antigen
BR0009077A (en) Tuberculosis antigens and methods of using them
AR010517A1 (en) COMPOUNDS AND METHODS FOR TUBERCULOSIS IMMUNOTHERAPY AND DIAGNOSIS
CY1108864T1 (en) UNIONS FOR IMMUNOTHERAPY AND TYPE DIAGNOSIS AND METHODS OF USE